Olanzapine-induced paraesthesia: A less reported side effect

Olanzapine is an atypical antipsychotic used to treat schizophrenia, bipolar disorder, and depression. Despite proven efficacy in these disorders, it can cause various side effects, including occurrences of paraesthesia-a sensory disorder characterized by spontaneous itching or tingling without external triggers. The mechanism behind olanzapine-induced paraesthesia is not well understood but may involve dopamine D2 and serotonin 5-HT2A and 5-HT2C receptor antagonism. Here, we report two cases of severe paraesthesia that occurred as a side effect of olanzapine therapy, which improved after discontinuing the medication in the first case and by reducing the dose in the second case.

Authors

Institutions

Publication Details

Journal
Indian Journal of Pharmacology
Published
2025-03-01
DOI
https://doi.org/10.4103/ijp.ijp_637_24
Citations
1
Primary Topic
Treatment of Major Depression
Type
article
Field-Weighted Citation Impact
1.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Olanzapine-induced paraesthesia: A less reported side effect

Sanjay Kumar Tyagi, Vijay Kumar Saini, Vishal Verma, Harmanpreet Kaur
1 citations
Indian Journal of Pharmacology
Treatment of Major Depression
1.39
article

Olanzapine-induced paraesthesia: A less reported side effect

Sanjay Kumar Tyagi, Vijay Kumar Saini, Vishal Verma, Harmanpreet Kaur
article en
1 citations

Abstract

Olanzapine is an atypical antipsychotic used to treat schizophrenia, bipolar disorder, and depression. Despite proven efficacy in these disorders, it can cause various side effects, including occurrences of paraesthesia-a sensory disorder characterized by spontaneous itching or tingling without external triggers. The mechanism behind olanzapine-induced paraesthesia is not well understood but may involve dopamine D2 and serotonin 5-HT2A and 5-HT2C receptor antagonism. Here, we report two cases of severe paraesthesia that occurred as a side effect of olanzapine therapy, which improved after discontinuing the medication in the first case and by reducing the dose in the second case.

Indian Journal of PharmacologyVol. 57(2)
All India Institute of Medical Sciences Jodhpur (IN)
Openalex Percentile: Top 19%
Treatment of Major Depression
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.